Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Isomaltoside for Postoperative Anemia in TKA
NCT03470649Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2018
- Primary completion
- Apr 2019
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of ferric derisomaltose in postoperative anemia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of Postoperative Anemia at 30 days. Started Mar 2018; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT03470649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03470649.